Given serum iron of 9 µg/dL, transferrin saturation of 11 %, hemoglobin 123 g/L with normal MCV, MCH, MCHC, and a mean platelet volume of 11.2 fL, what is the likely diagnosis and recommended management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Iron Deficiency Without Anemia

Based on your laboratory values showing low serum iron (9 µg/dL) and low transferrin saturation (11%), you have iron deficiency without anemia, and should begin oral iron supplementation immediately. 1

Diagnosis

Your labs demonstrate clear iron deficiency:

  • Serum iron of 9 µg/dL is markedly low (normal range typically 60-170 µg/dL)
  • Transferrin saturation of 11% is below the diagnostic threshold (normal >20%) 2
  • Hemoglobin 123 g/L (12.3 g/dL) is normal, ruling out anemia
  • Normal MCV (86 fL), MCH (27 pg), and MCHC (318 g/L) indicate your red blood cells are still normal-sized and normally filled with hemoglobin—this is early iron deficiency before it progresses to anemia

The elevated mean platelet volume (11.2 fL) is consistent with iron deficiency, as iron deficiency commonly causes reactive thrombocytosis and increased platelet parameters 3. This finding actually supports the diagnosis rather than suggesting an alternative condition.

Why This Matters

Iron deficiency without anemia affects 39% of premenopausal women and 8% of postmenopausal women in the United States 1. Treating at this stage prevents progression to iron deficiency anemia and improves quality of life before hemoglobin drops further.

Recommended Management Algorithm

Step 1: Initiate Oral Iron Supplementation

Start with ferrous sulfate, ferrous fumarate, or ferrous gluconate as first-line therapy 1. These are equally effective and typically least expensive.

Dosing strategy:

  • Take on an empty stomach for optimal absorption
  • If gastrointestinal side effects occur (nausea, abdominal pain, constipation), take with meals instead
  • Consider taking with 500 mg vitamin C to enhance absorption 1
  • Taking with meat protein also improves absorption 1

Step 2: Investigate the Underlying Cause

While starting iron replacement, evaluate for:

  • Dietary iron intake assessment (inadequate consumption of iron-rich foods)
  • Menstrual blood losses if premenopausal woman
  • Gastrointestinal causes: occult blood loss, malabsorption conditions, Helicobacter pylori infection 1
  • Consider celiac disease screening if malabsorption suspected

Step 3: Monitor Response

Recheck complete blood count and iron studies after 8-12 weeks of oral supplementation to confirm:

  • Rising hemoglobin (if it begins to drop)
  • Increasing transferrin saturation (target >20%)
  • Improving serum iron

Step 4: Consider IV Iron if Oral Fails

Switch to intravenous iron if 1:

  • Oral iron is not tolerated despite trying different formulations
  • Iron stores fail to improve after adequate trial of oral therapy
  • Gastrointestinal malabsorption is documented
  • Ongoing blood losses exceed oral replacement capacity

Critical Pitfall to Avoid

Do not wait for anemia to develop before treating. Your transferrin saturation of 11% with low serum iron definitively establishes iron deficiency 2, 4. The normal hemoglobin and red cell indices simply indicate you're in the early stage before tissue iron depletion causes microcytic anemia. Early intervention prevents progression and maintains quality of life 1.

The normal MCV, MCH, and MCHC can falsely reassure clinicians, but iron deficiency is present in heart failure patients across all red cell index categories, from 75% with low indices to 36% with normal indices 5. Your iron parameters, not your red cell size, drive the diagnosis.

References

Research

Diagnosis and management of iron-deficiency anaemia.

Best practice & research. Clinical haematology, 2005

Research

Assessing iron status: beyond serum ferritin and transferrin saturation.

Clinical journal of the American Society of Nephrology : CJASN, 2006

Research

Iron deficiency and red cell indices in patients with heart failure.

European journal of heart failure, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.